Longevity World Forum (LWF) continues to make progress in shaping its 2027 edition with the confirmation of new internationally renowned figures in the fields of genetics, the biology of aging, neuroscience, preventive medicine, and research into healthy aging: George Church, Russell Foster, and Fátima Bosch.
Their participation reinforces the scientific and international character of an event that aims to continue connecting — from Spain — the leading researchers, scientists, technologists, and professionals who are defining the future of longevity.
The fifth edition of the Longevity World Forum will take place on February 10, 11, and 12, 2027, at La Nave, Madrid, and will be structured around three main areas: science, trends, and entrepreneurship, with particular attention to research, prevention, genetics, medical technology, and the social impact of advances in longevity.
From the Genomic Revolution to New Strategies Against Aging
Among the confirmed names is George Church, Professor of Genetics at Harvard Medical School and one of the most internationally recognized figures in the development of genomics and synthetic biology.
Church participated in the development of some of the first direct genome sequencing methodologies, and his research has helped advance next-generation sequencing technologies, cellular and tissue engineering, and various biotechnological applications.
He is also director of PersonalGenomes.org, an initiative that provides the world’s only open-access platform containing information on human genomic, environmental, and trait data, and of the NIH Center for Excellence in Genomic Science. He has also been elected a member of the National Academy of Sciences and the National Academy of Engineering.
His participation will bring to the Longevity World Forum a particularly relevant perspective on the role of genomics, genetic engineering, and synthetic biology in the medicine of the future, as well as the possibilities and challenges posed by the use of these technologies to understand and address age-related diseases.
Sleep, Circadian Rhythms, and Health Throughout Life
Also joining the program is Russell Foster, who directs the Nuffield Laboratory of Ophthalmology at the University of Oxford, is the founder and director of the Sleep and Circadian Research Institute, and is a Fellow of Brasenose College, Oxford.
Foster is a world-renowned authority on the study of circadian rhythms and sleep. His research has helped characterize a previously unknown light-detection system in the eye, linked to the regulation of circadian rhythms and sleep. His work also examines how these systems are disrupted as a result of aging, disease, and certain social factors.
His presence at LWF 2027 will provide an opportunity to address a fundamental dimension of healthy aging: the relationship between sleep, light, biological rhythms, and health, bringing decades of accumulated knowledge in neuroscience and chronobiology into the debate on longevity.
Gene Therapy and Biotechnology Applied to Metabolic Diseases
The participation of Fátima Bosch, researcher and professor at the Universitat Autònoma de Barcelona, adds to the program the expertise of one of Spain’s most distinguished scientists in gene therapy and biotechnology.
Bosch was a pioneer in the development of transgenic animal models in Spain and established the country’s first transgenic animal laboratory at the UAB in 1990, which later became the Center for Animal Biotechnology and Gene Therapy (CBATEG), which she has directed ever since. Her research has focused particularly on the use of gene therapy to address metabolic diseases.
Throughout her career, she has received numerous scientific distinctions, including the Creu de Sant Jordi, the Narcís Monturiol Medal, the King Juan Carlos I Award, and the Jacob’s Ladder Norman Saunders International Research Prize. In 2022, she was elected a full member of the Royal Academy of Sciences and Arts of Barcelona.
Her participation in LWF will help explore the potential of gene therapy and biotechnology to prevent or treat age-related conditions, as well as the challenges involved in translating basic and experimental research into new therapeutic applications.
An International Meeting Point for Longevity Science
The addition of Church, Foster, and Bosch reinforces the international vocation of the Longevity World Forum, which, since its earliest editions, has sought to bring together researchers, physicians, scientific technologists, companies, startups, and professionals from different disciplines related to longevity in Spain.
In previous editions, the congress has featured leading international figures and continues to expand a community that connects fields as diverse as genetics, epigenetics, preventive medicine, geroscience, artificial intelligence, nutrition, exercise, biotechnology, and regenerative medicine. The organizers define the event as a space for sharing knowledge and generating synergies between the scientific community, the innovation ecosystem, and the industry linked to longevity and healthy aging.
With this new edition, Madrid consolidates its position as a meeting point for discussions on one of the major scientific and social challenges of the coming decades: not only living longer, but also gaining a better understanding of the mechanisms of aging and promoting longer life expectancy in good health.
The fifth edition of the Longevity World Forum will take place on February 10, 11, and 12, 2027, at La Nave, Madrid. Over three days, the event will bring together national and international experts to address the latest scientific, technological, and business developments related to longevity and healthy aging.
More information: www.longevityworldforum.com
